Revelo, Justine .
HRN: 23-92-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
06/04/2025
06/09/2025
PO
11.6ml
OD
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes